CITIGROUP INC - COMPASS THERAPEUTICS INC ownership

COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 35 filers reported holding COMPASS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of COMPASS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$361
-99.6%
183
-99.4%
0.00%
Q2 2023$92,500
-80.2%
29,088
-79.7%
0.00%
Q1 2023$467,417
-26.4%
142,941
+13.2%
0.00%
-100.0%
Q4 2022$635,364
+6253.6%
126,315
+2686.6%
0.00%
Q3 2022$10,000
+150.0%
4,533
+230.9%
0.00%
Q2 2022$4,000
-96.7%
1,370
-96.4%
0.00%
Q4 2021$120,00037,8340.00%
Other shareholders
COMPASS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,500,000$11,165,0007.28%
Foresite Capital Management V, LLC 4,400,000$13,948,0003.43%
CHI Advisors LLC 3,023,692$9,585,0003.18%
Foresite Capital Opportunity Management V, LLC 1,100,000$3,487,0002.34%
Monashee Investment Management LLC 2,000,000$6,340,0001.57%
Orbimed Advisors 21,642,975$68,608,0000.88%
Rock Springs Capital Management LP 5,328,088$16,890,0000.39%
Vivo Capital, LLC 2,000,000$6,340,0000.38%
SPHERA FUNDS MANAGEMENT LTD. 700,000$2,219,0000.24%
DAFNA Capital Management LLC 196,091$622,0000.16%
View complete list of COMPASS THERAPEUTICS INC shareholders